[
1. Chu JS. Prognostic factors in phyllodes tumor of the breast: are immunohistochemical biomarkers useful? J Chin Med Assoc 2004; 67: 1-2.
]Search in Google Scholar
[
2. Mylvaganam S, Toro C, Frank L, Vesty S, Thrush S. Phyllodes tumors of the breast: the best practice for follow-up. Updat Surg 2015; 67: 91-5.10.1007/s13304-015-0278-325575495
]Search in Google Scholar
[
3. Wang H, Wang X, Wang CF. Comparison of clinical characteristics between benign borderline and malignant phyllodes tumors of the breast. Asian Pac J Cancer Prev 2014; 15: 10791-5.10.7314/APJCP.2014.15.24.1079125605178
]Search in Google Scholar
[
4. Yom CK, Han W, Kim SW, Park SY, A. Park IA, Noh DY. Reappraisal of conventional risk stratification for local recurrence based on clinical outcomes in 285 resected phyllodes tumors of the breast. Ann Surg Oncol 2015; 22: 2912-8.10.1245/s10434-015-4395-525652050
]Search in Google Scholar
[
5. Rodrigues MF, Truong PT, McKevitt EC, Weir LM, Knowling MA, Wai ES. Phyllodes tumors of the breast: the British Columbia cancer agency experience. Cancer Radiother 2018; 22: 112-9.10.1016/j.canrad.2017.08.11229523388
]Search in Google Scholar
[
6. National Comprehensive Cancer Network Breast Cancer. Clinical Practice Guidelines in Oncology (NCCN Guidelines). Plymouth Meeting, PA: NCCN; 2019.
]Search in Google Scholar
[
7. Chang J, Denham L, Dong EK, Malek K, Lum SS. Trends in the diagnosis of phyllodes tumors and fibroadenomas before and after release of WHO classification standards. Annals of Surgical Oncology 2018; 25: 3088-95.10.1245/s10434-018-6622-329987607
]Search in Google Scholar
[
8. Wei J, Tan Y, Cai Y, et al. Predictive factors for the local recurrence and distant metastasis of phyllodes tumors of the breast : a retrospective analysis of 192 cases at a single center. China J Cancer.2014 ;33: 492-50010.5732/cjc.014.10048419875225104281
]Search in Google Scholar
[
9. Onkendi EO, Jimenez RE, Spears GM, Harmsen WS, Ballman KV, Hieken TJ. Surgical treatment of borderline and malignant phyllodes tumors: the effect of the extent of resection and tumor characteristics on patient outcome. Ann Surg Oncol 2014; 21(10): 3304-9.10.1245/s10434-014-3909-x25034817
]Search in Google Scholar
[
10. Abe H, Teramoto A, Takei Y, Tanaka Y, Yoneda G. Malignant phyllodes of the breast with rapid progression: a case report. Surg Case Rep 2020; 6: 308.10.1186/s40792-020-00986-8772195833284362
]Search in Google Scholar
[
11. Spanheimer PM, Murray MP, Zabor EC, Stempel M, Morrow M, Van Zee KJ, et al. Long-term outcomes after surgical treatment of malignant/borderline phyllodes tumors of the breast. Ann Surg Oncol 2019; 26(7): 2136-43.10.1245/s10434-019-07210-4654525830783853
]Search in Google Scholar
[
12. Thind A, Patel B, Thind K, Isherwood J, Phillips B, Dhaliwal K, et al. Surgical margins for borderline and malignant phyllodes tumours. Ann R Coll Surg Engl 2020; 102(3): 165-73.10.1308/rcsann.2019.0140702742331918563
]Search in Google Scholar
[
13. Sawalhi S, Al-Shatti M. Phyllodes tumor of the breast: a retrospective study of the impact of histopathological factors in local recurrence and distant metastasis. Ann Saudi Med 2013; 33(2): 162-8.10.5144/0256-4947.2013.162607861823563006
]Search in Google Scholar
[
14. Shubham S., Ahuja A, Bhardwaj M. Immunohistochemical expression of Ki-67, p53, and CD10 in phyllodes tumor and their correlation with its histological grade. J Lab Physicians 2019; 11(4): 330-4.10.4103/JLP.JLP_106_19694386531929699
]Search in Google Scholar
[
15. Spitaleri G, Toesca A, Botteri E, Bottiglieri L, Rotmensz N, Boselli S, et al. Breast phyllodes tumor: a review of literature and a single center retrospective series analysis. Crit Rev Oncol Hematol 2013; 88(2): 427-3610.1016/j.critrevonc.2013.06.00523871531
]Search in Google Scholar
[
16. Kim YJ, Kim K. Radiation therapy for malignant phyllodes tumor of the breast: an analysis of SEER data. Breast 2017; 32: 26-32.10.1016/j.breast.2016.12.00628013032
]Search in Google Scholar
[
17. Gnerlich JL, Williams RT, Yao K, Jaskowiak N, Kulkarni SA. Utilization of radiotherapy for malignant Phyllodes tumors: analysis of the National Cancer Data Base, 1998-2009. Ann Surg Oncol. 2014;21(4):1222-1230.10.1245/s10434-013-3395-624306659
]Search in Google Scholar
[
18. Varghese SS, Sasidharan B, Manipadam MT, Paul MJ, Backianathan S. Radiotherapy in phyllodes tumour. J Clin Diagn Res 2017; 11(1): XC01-XC03.10.7860/JCDR/2017/24591.9167532447428274029
]Search in Google Scholar
[
19. Morales-Vásquez F, Gonzalez-Angulo AM, Broglio K, Lopez-Basave HN, Gallardo D, Hortobagyi GN, et al. Adjuvant chemotherapy with doxorubicin and dacarbazine has no effect in recurrence-free survival of malignant phyllodes tumors of the breast. Breast J. 2007; 13(6): 551-6.10.1111/j.1524-4741.2007.00510.x17983394
]Search in Google Scholar
[
20. Spasić M, Milošević B, Mitrović S, Marković N, Pavlović M, Jevdjić J, et al. Giant exulcerated phylloid breast tumor - a case report. Serbian Journal of Experimental and Clinical Research 2020; 21(1): 83-6.10.2478/sjecr-2018-0014
]Search in Google Scholar
